August 25, 2026 by Mohr Marketing
Paying for lead volume is the fastest way to erode your firm's margin in a 2026 market where acquisition costs have surged by 13% in just a few...
August 22, 2026 by Mohr Marketing
The era of broad PFAS marketing is over. Firms still chasing those dismissed claims are burning capital on non-viable leads. Effective advertising...
August 21, 2026 by Mohr Marketing
The dismissal of major PFAS class actions in 2025 didn't end the opportunity for growth; it merely shifted the battlefield to heavy metal...
August 20, 2026 by Mohr Marketing
While the global tampon market reaches an estimated $7.25 billion in 2026, the legal landscape is pivoting toward a high-stakes battle over medical...
August 17, 2026 by Mohr Marketing
Buying leads in 2026 is a liability, not an asset. If your intake department is currently overwhelmed by no-contact leads while your marketing budget...
August 16, 2026 by Mohr Marketing
The cheapest lead on your balance sheet is often the most expensive mistake your firm will make this year. Competition for high-stakes litigation is...
August 10, 2026 by Mohr Marketing
Mass tort marketing budgets are being liquidated by unqualified inquiries and opaque attribution. If your intake team spends more time disqualifying...
August 4, 2026 by Mohr Marketing
A massive lead volume is often the fastest way to bankrupt a mass tort marketing budget. If your firm is struggling with non-responsive inquiries or...
July 23, 2026 by Mohr Marketing
The July 2026 FDA report hasn't ended the tampon heavy metal contamination lawsuit; it has simply raised the threshold for medical causation. Law...
July 22, 2026 by Mohr Marketing
The belief that the July 2026 FDA study would end the tampon toxic metal crisis was a strategic miscalculation for manufacturers. While federal...